NEW YORK (GenomeWeb News) – Metabolomics company Molecular Biometrics said yesterday that it has completed a $12.5 million Series B financing.
New investor Atlas Ventures led the financing round with participation from existing investors Safeguard Scientifics and Oxford Bioscience Partners.
Based in Norwood, Mass., Molecular Biometrics will use the cash to accelerate the global launch of its lead product, ViaMetrics-E, a rapid, non-invasive procedure designed to enhance in vitro fertilization outcomes by using cellular metabolomic signatures.